MARIETTA, Ga. (AP) _ MiMedx Group Inc. (MDXG) on Tuesday reported a loss of $3.3 million in its second quarter.

On a per-share basis, the Marietta, Georgia-based company said it had a loss of 3 cents.

The results surpassed Wall Street expectations. The average estimate of three analysts surveyed by Zacks Investment Research was for a loss of 7 cents per share.

The developer of biomaterials made from sterilized human amniotic membrane posted revenue of $68.2 million in the period, which also beat Street forecasts. Three analysts surveyed by Zacks expected $58.8 million.

MiMedx shares have climbed 38% since the beginning of the year. In the final minutes of trading on Tuesday, shares hit $12.55, more than doubling in the last 12 months.

This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on MDXG at https://www.zacks.com/ap/MDXG

Copyright by Automated Insights, Inc. All rights reserved., source Associated Press News